Posts Tagged ‘biotech’
Research and development tax relief ‘single scheme’ consultation launched
R&D tax reliefs are very much in the news, due in large part to major changes being made to the schemes by Government. The past decade has seen upheaval in the way the R&D schemes work, including which costs are eligible, complexity around subcontractor costs, and the latest move – Jeremy Hunt’s 50% cut in…
Read MoreBiotech Employee Equity Survey 2020 results – BEES
The Employee Equity Survey was run for biotech companies to enable them to benchmark equity distribution and the size of share option pools..
Read MoreR&D tax credits: PAYE cap implemented in 2021
But there is no need to panic as most companies, including those in biotech and tech, will be minimally affected by the changes. The PAYE cap legislation around SME R&D claims has been released by HMRC (November 12). Crucially, the exemption to the cap that we, together with the BIA, lobbied hard for, has been included. The key takeaway messages from today’s…
Read MoreBudget 2020 tax update for biotech and tech companies
THE 2020 Budget was an interesting one, especially for biotech companies. Confluence Tax’s team presented the headline points during the company’s Post-Budget Briefing event held on March 12. The focus was on the main elements that will affect companies from a tax and finance perspective.
Read MoreConfluence Tax: registered tax agents in Ireland
PRESS RELEASE August 29, 2019 We are delighted to announce that Confluence Tax is now registered as a tax agent in the Republic of Ireland. Many UK-based companies that need to retain a foothold within the EU following Brexit – for regulatory reasons, for example – are establishing Irish subsidiaries. This is driving the need for tax advice and support…
Read More